Logo

BARDA DRIVe Accelerator

Fostering the growth of the global health security innovation ecosystem

Washington, DC, USA

Apply

Description

The BARDA DRIVe (Division of Research, Innovation, and Ventures) Accelerator Network is a strategic initiative by the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS). It is a public-private partnership designed to accelerate the development of health security solutions. It is specifically designed to move products through the "Valley of Death" between initial research and commercial viability. 

  • Method: Founders do not apply to the government directly first; they engage with one of the 13 regional accelerators in the network (e.g., Texas Medical Center, University City Science Center, or SUNY).
  • Submission: Startups submit a pitch deck and a "Market Input" or "White Paper" tailored to specific BARDA areas of interest (AOI).
  • Focus: Areas include Sepsis detection, early notification of infection, and wearable sensors for health security. 

Eligibility

  • Sector: Health Security, MedTech, Biotechnology, and Diagnostics.
  • Solution Alignment: Must address current DRIVe priorities (e.g., "Digital Health," "Re-imagining Respiratory Protection," or "Home-based Diagnostics").
  • Geography: Primarily United States-based companies, though international firms can occasionally participate if the solution is critical to U.S. health security. 

Process

  1. Accelerator Engagement: A startup connects with a regional accelerator for vetting and mentorship.
  2. Abstract Submission: The accelerator helps the founder submit a short abstract/white paper to BARDA.
  3. In-Depth Review: If invited, the startup submits a full proposal for non-dilutive funding or the Blue Knight residency.
  4. Award: BARDA DRIVe provides funding via EZ-BAA (an expedited contracting process) or other investment vehicles. 

What an Applicant can Obtain

  • Non-Dilutive Capital: Funding through EZ-BAA awards, typically up to $750,000 for initial phases.
  • Blue Knight: A joint residency program with Johnson & Johnson Innovation (JLABS) providing lab space and mentorship.
  • Subject Matter Expertise: Direct access to government scientists and clinicians to guide regulatory and clinical strategy.